Sera Prognostics (SERA) Liabilities and Shareholders Equity (2020 - 2026)

Sera Prognostics (SERA) posted Liabilities and Shareholders Equity of $93.5 million for Q1 2026, down 8.23% on a QoQ basis from $101.9 million in Q4 2025, and down 20.85% year-over-year from $118.2 million in Q1 2025.

Sera Prognostics (SERA) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Sera Prognostics' Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $93.5 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 20.85% year-over-year to $93.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $415.4 million (up 17.15% YoY) and the FY2025 annual result came in at $101.9 million, up 40.45% from the prior year.
  • Liabilities and Shareholders Equity was $93.5 million for Q1 2026 at Sera Prognostics, down from $101.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $134.9 million in Q1 2022 and bottomed at $72.6 million in Q4 2024.
  • A 5-year average of $102.4 million and a median of $101.9 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 24.16% — and 2025, when it soared 40.45%.
  • Sera Prognostics' Liabilities and Shareholders Equity stood at $116.3 million in 2022, then slipped by 17.96% to $95.4 million in 2023, then slipped by 23.96% to $72.6 million in 2024, then jumped by 40.45% to $101.9 million in 2025, then retreated by 8.23% to $93.5 million in 2026.
  • Business Quant data shows SERA's Liabilities and Shareholders Equity at $93.5 million in Q1 2026, $101.9 million in Q4 2025, and $108.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 184.16 Bn 176.87 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.86 Bn 125.98 Bn 3.81 Bn 46.29 Bn
3 Medtronic 108.89 Bn 99.67 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 68.54 Bn 67.08 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 47.44 Bn 43.76 Bn 1.29 Bn 13.32 Bn
6 GE HealthCare Technologies 28.45 Bn 26.16 Bn 1.98 Bn 37.13 Bn
7 Dexcom 28.36 Bn 27.24 Bn 750.30 Mn 6.63 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 10.46 Bn
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn 31.92 Bn
10 Sera Prognostics 102.28 Mn 102.28 Mn -28,000.00 93.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 93.54 Mn
Dec 31, 2025 101.93 Mn
Sep 30, 2025 108.13 Mn
Jun 30, 2025 111.83 Mn
Mar 31, 2025 118.18 Mn
Dec 31, 2024 72.58 Mn
Sep 30, 2024 79.00 Mn
Jun 30, 2024 84.86 Mn
Mar 31, 2024 89.89 Mn
Dec 31, 2023 95.44 Mn
Sep 30, 2023 90.06 Mn
Jun 30, 2023 96.68 Mn
Mar 31, 2023 105.61 Mn
Dec 31, 2022 116.33 Mn
Sep 30, 2022 116.56 Mn
Jun 30, 2022 125.06 Mn
Mar 31, 2022 134.87 Mn
Dec 31, 2021 147.03 Mn
Sep 30, 2021 153.69 Mn
Jun 30, 2021 95.07 Mn